2006
DOI: 10.1021/jm051121i
|View full text |Cite
|
Sign up to set email alerts
|

Novel Potent and Efficacious Nonpeptidic Urotensin II Receptor Agonists

Abstract: Six different series of nonpeptidic urotensin II receptor agonists have been synthesized and evaluated for their agonistic activity in a cell-based assay (R-SAT). The compounds are ring-opened analogues of the isochromanone-based agonist AC-7954 with different functionalities constituting the linker between the two aromatic ring moieties. Several of the compounds are highly potent and efficacious, with N-[1-(4-chlorophenyl)-3-(dimethylamino)-propyl]-4-phenylbenzamide oxalate (5d) being the most potent. The pur… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
11
0

Year Published

2009
2009
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 31 publications
(11 citation statements)
references
References 34 publications
0
11
0
Order By: Relevance
“…In addition to sEH inhibitors, the 1, 3-disubstituted urea moiety is frequently used in medicinal chemistry and is reported to possess various biological activities [7178]. For example, many of the kinase inhibitors, including the marketed anticancer drugs sorafenib and regorafenib, have 1, 3-disubstituted urea-based structure with antitumor activity [79].…”
Section: Resultsmentioning
confidence: 99%
“…In addition to sEH inhibitors, the 1, 3-disubstituted urea moiety is frequently used in medicinal chemistry and is reported to possess various biological activities [7178]. For example, many of the kinase inhibitors, including the marketed anticancer drugs sorafenib and regorafenib, have 1, 3-disubstituted urea-based structure with antitumor activity [79].…”
Section: Resultsmentioning
confidence: 99%
“…11, compound 18, Acadia Pharmaceuticals; EC 50 : 32 nM) and its optimized (+)-(S)-naphtyl-containing derivative (Fig. 11, compound 19, Acadia Pharmaceuticals; EC 50 : 23 nM) (Lehmann et al, 2006(Lehmann et al, , 2009.…”
Section: Design Of Nonpeptidic Urotensin II Receptor Agonists and mentioning
confidence: 99%
“…Alternatively, non‐acidic approaches to methylation exist that may obviate the above concerns. In this study, we tested a non‐acidic method using 1‐ethyl‐3‐(3‐dimethylaminopropyl)carbodiimide (EDCI) as a coupling reagent with 4‐dimethylaminopyridine (DMAP) as the catalyst (Figure ) . Carbodiimides, due to their accessibility and versatility, are ranked as one of the most important classes of compounds in organic chemistry .…”
Section: Introductionmentioning
confidence: 99%